Clinical Trial Update: Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of Visudyne (verteporfin) with Kenalog (triamcinolone) for choroidal neovascularization due to age-related macular dege…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• Visudyne (verteporfin)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED